IRIDEX Corporation
General ticker "IRIX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $19.8M (TTM average)
IRIDEX Corporation does not follow the US Stock Market performance with the rate: -3.5%.
Estimated limits based on current volatility of 2.3%: low 0.92$, high 0.96$
Factors to consider:
- Total employees count: 93 (0.0%) as of 2026
- US accounted for 50.2% of revenue in the fiscal year ended 2023-12-30
- Top business risk factors: Dependence on topcon partner, Quality control failures, Geopolitical risks, Supply chain disruptions, Regulatory and compliance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-03 to 2028-01-03
- 2026-01-03 to 2027-01-03 estimated range: [0.88$, 2.04$]
- 2027-01-03 to 2028-01-03 estimated range: [1.07$, 2.37$]
Financial Metrics affecting the IRIX estimates:
- Positive: with PPE of -4.3 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Positive: Inventory ratio change, % of -5.70 <= -0.75
- Positive: -5.34 < Operating profit margin, % of -4.65
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term IRIX quotes
Long-term IRIX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2026-01-03 |
|---|---|---|---|
| Operating Revenue | $51.87MM | $48.67MM | $52.67MM |
| Operating Expenses | $61.88MM | $56.97MM | $55.25MM |
| Operating Income | $-10.01MM | $-8.30MM | $-2.57MM |
| Non-Operating Income | $0.53MM | $-0.54MM | $-1.81MM |
| R&D Expense | $6.83MM | $5.45MM | $3.67MM |
| Income(Loss) | $-9.48MM | $-8.84MM | $-4.38MM |
| Taxes | $0.09MM | $0.07MM | $0.06MM |
| Net Income(Loss)* | $-9.57MM | $-8.91MM | $-4.44MM |
| Stockholders Equity | $9.52MM | $2.10MM | $4.92MM |
| Inventory | $9.91MM | $10.82MM | $7.88MM |
| Assets | $34.44MM | $29.14MM | $29.15MM |
| Operating Cash Flow | $-6.75MM | $-7.29MM | $-2.12MM |
| Capital expenditure | $0.11MM | $0.01MM | $0.14MM |
| Investing Cash Flow | $-0.11MM | $-0.01MM | $-0.14MM |
| Financing Cash Flow | $-0.01MM | $2.60MM | $5.96MM |
| Earnings Per Share** | $-0.59 | $-0.54 | $-0.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.